Nanosecond PFA 360° Cardiac Catheter for AF ablation to be highlighted in presentations and in a live case transmission “We are gaining significant momentum generating clinical and preclinical ...
Pulse BioSciences’ CTO knows what it takes to create successful medtech and sometimes, it takes partnering with the competition.
The Pulse Technology family and team took a moment from the 70th anniversary celebration to pose for this photo in the company's front lobby. Courtesy of Suzanne Fasolo/Pickle Book Designs. (L-R) Tom ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced ...
Clinical Data on Benign Thyroid Nodule Ablation to be highlighted in presentation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary ...
Clinical Data on Benign Thyroid Nodule Ablation to be highlighted in presentation “We believe the differentiated nPulse Vybrance Percutaneous Electrode system is setting a new standard for safety, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results